Clinical trial
Bioequivalence and Safety Study of Lidocaine and Prilocaine Cream in Healthy Chinese Subjects : A Randomized, Open-label, Single-dose, Two-period, Cross-over Study
NCT07551713 is registered in ClinicalTrials.gov with Haisco Pharmaceutical Group Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bioequivalence and Safety Study of Lidocaine and Prilocaine Cream in Healthy Chinese Subjects : A Randomized, Open-label, Single-dose, Two-period, Cross-over Study
- Lead sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 11, 2020
- Completion date
- September 28, 2020
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy